The New York automation company says fresh capital will fund new products and a deeper healthcare push, after passing $200M…
The Emeryville lab will use its protein language models to generate enzyme candidates that BioMarin screens and can advance toward…
Microsoft Research's Quine links biology models, lab tools and published literature into one loop that already surfaced tumor-shifting compounds.
An AI search over excipient blends kept mRNA vaccines potent for months at high heat, a step toward freeing clinical…
Red Queen Bio has raised $36M to build AI-designed antibody drugs fast enough to outrun whatever frontier models might enable.
HITS, the KAIST spinout, has raised $13.4M to put AI agents that search literature, analyze data and test hypotheses into…
The Australian biotech will use Amazon's cloud and AI tools across discovery and clinical development, from target hunting to regulatory…
A Boston company working on technology licensed from Mass General Brigham wants AI to connect evidence across entire preclinical safety…